Cardiovascular Outcomes and Risk Evaluation Among Recipients of Hematopoietic Stem Cell Transplantation

NCT07349498 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2026-01-16

No results posted yet for this study

Summary

This is a prospective, multicenter observational study for recipients of hematopoietic stem cell transplantation. Patients who underwent hematopoietic stem cell transplantation at the participating centers will be entrolled in the study. The clinical characteristics, laboratory profiles, management measures, and clinical outcomes such as post-transplant cardiovascular events will be prospectively collected.

Conditions

Sponsors & Collaborators

  • Hematology Hospital of Chinese Academy of Medical Sciences (Hematology Research Center of Chinese Academy of Medical Sciences)

    collaborator UNKNOWN
  • First Affiliated Hospital of Zhejiang University

    collaborator OTHER
  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    collaborator OTHER
  • Tongji Hospital, Affiliated to Tongji Medical College of Huazhong University of Science and Technology

    collaborator UNKNOWN
  • Xinqiao hospital of the third military medical university

    collaborator UNKNOWN
  • The First Affiliated Hospital of Zhengzhou University

    collaborator OTHER
  • Sun Yat-sen University Cancer Center, Sun Yat-sen University

    collaborator UNKNOWN
  • Sichuan Provincial People's Hospital

    collaborator OTHER
  • First Affiliated Hospital of Harbin Medical University

    collaborator OTHER
  • First Affiliated Hospital Xi'an Jiaotong University

    collaborator OTHER
  • First Affiliated Hospital of Xinjiang Medical University

    collaborator OTHER
  • Chinese PLA General Hospital

    collaborator OTHER
  • Peking University Shenzhen Hospital

    collaborator OTHER
  • Peking University Third Hospital

    collaborator OTHER
  • Peking University First Hospital

    collaborator OTHER
  • Peking University People's Hospital

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-01
Primary Completion
2036-06-30
Completion
2036-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07349498 on ClinicalTrials.gov